about
Asthma-related comorbidities.Unusual asthma syndromes and their managementAnti-IgE--emerging opportunities for Omalizumab.Severe asthma and the omalizumab option.Moving toward consensus on diagnosis and management of severe asthma in adults.Off-label use of omalizumab in non-asthma conditions: new opportunities.Variability of total and free IgE levels and IgE receptor expression in allergic subjects in and out of pollen season.
P2860
Q34195201-25A92F10-C6F8-43E0-BCFC-3E3C75AB597FQ36443760-2C2ECC81-3A9D-428A-B037-345E46A38CEAQ38091754-F304AF61-CEFA-4630-A2FB-633FFFE499F2Q40740336-FFDFC48A-B028-40E3-ACE6-2DBBD89425B7Q50106766-13329569-1CDC-4456-AE12-B71AEB95CF13Q51770958-A5B5585A-C31D-4569-B979-67BB4B5A57B1Q53628624-086B22E3-4825-4489-B84D-6A06CD58AEBA
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Anti-IgE in allergic asthma and rhinitis: an update.
@en
type
label
Anti-IgE in allergic asthma and rhinitis: an update.
@en
prefLabel
Anti-IgE in allergic asthma and rhinitis: an update.
@en
P2093
P2860
P1476
Anti-IgE in allergic asthma and rhinitis: an update.
@en
P2093
Gnanasekaran Gnanakumaran
Jaymin B Morjaria
Kesavan Suresh Babu
P2860
P304
P356
10.1517/14712598.7.11.1739
P407
P577
2007-11-01T00:00:00Z